News | February 08, 2022
Suven Pharma Q3FY22 PAT at Rs. 160.06 crore
Suven Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Suven Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021
IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021
Dishman Carbogen Amcis has reported consolidated financial results for the period ended December 31, 2021
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
The company has reported standalone financial results for the period ended December 31, 2021.
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
This will evaluate the immunogenicity, safety, and reactogenicity of a single booster dose in adults aged 18 years and older
Subscribe To Our Newsletter & Stay Updated
